Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06901284 · ClinicalTrials.gov registry record

Graded Exercise Hypoxia Testing

A clinical trial of Hypoxia, sponsored by Mayo Clinic.

Active
Registry status
50
Enrollment target
2
Study locations

NCT06901284: Active study of Hypoxia, sponsored by Mayo Clinic.

NCT06901284 is a study of Hypoxia that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06901284, a study of Hypoxia, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
50 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to develop a single, standardized test to determine how individuals tolerate acute hypoxia in a stepwise fashion. We aim to evaluate the association between multiple factors, such as ventilatory compensation, heart rate response, acid-base changes, sex, pulmonary function, etc, which may explain why some individuals tolerate exercise in hypoxia better than others. Identifying these factors of association will inform future pharmacological and non-pharmacological attempts to combat acute hypoxic exercise.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Graded Exercise Test
  • DIAGNOSTIC_TEST Graded Hypoxia Exercise Test

Study Locations (2)

Minnesota

  • Mayo Clinic - Rochester
  • St. Mary's Hospital - Rochester

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-04-15
Est. Completion 2028-04-24

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06901284

The ClinicalTrials.gov registry entry for NCT06901284 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Graded Exercise Test is the first listed.

NCT06901284 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06901284 about?

NCT06901284 is a clinical study titled "Graded Exercise Hypoxia Testing". The purpose of this study is to develop a single, standardized test to determine how individuals tolerate acute hypoxia in a stepwise fashion. We aim to evaluate the association between multiple factors, such as ventilatory compensation, heart rate response, acid-base changes, sex, pulmonary functio...

What is the current status of trial NCT06901284?

This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2025-04-15. Estimated completion is 2028-04-24.

What conditions does trial NCT06901284 study?

This clinical trial studies the following conditions: Hypoxia.

What interventions are being tested in trial NCT06901284?

The interventions under investigation include: Graded Exercise Test (DIAGNOSTIC_TEST), Graded Hypoxia Exercise Test (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06901284?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06901284 being conducted?

This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.